Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...

If you are worried about using this medicine, speak to your doctor or pharmacist. INVEGA HAFYERA contains the active ingredient paliperidone palmitate. INVEGA HAFYERA is used to treat ...

Medications belonging to this family of drugs include: Oxybutynin: Available in tablet form (under its generic name) and transdermal patch (under brand name Oxytrol) Tolterodine: Available in tablet ...

Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart disease every 33 seconds. It remains the number one killer in the country. So it’s no ...

Sober when they arrived, Ms. Vlakos and her boyfriend were placed in a barely furnished two-bedroom apartment with a succession of strangers who often used drugs. She relapsed after a month.

unsealed ruling shows Schizophrenia drug had nearly $3 billion in US sales in 2023 Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal judge that unexpected results and industry ...

James B. Rebitzer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Shandong Jincheng Pharmaceutical Co., Ltd., Zibo, Shandong 255129, P. R. China ...